Robert F Friel
CIK 1224110 · Chairman and CEO · last filed 2026-05-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PKI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WALTHAM, MA 02451
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XYL | Director | 38,706 | $104.05 | $4.03M | $0 | 14 | 2026-05-15 |
| WST | Director | 5,512 | $384.02 | $2.12M | $0 | 8 | 2026-05-06 |
| NUVASIVE INC (NUVA) Delisted | Director | — | $39.75 | — | $0 | 10 | 2023-09-05 |
| REVVITY, INC. (PKI) Delisted | Chairman and CEO | 570,662 | $115.24 | $65.76M | -$96.71M | 45 | 2019-02-14 |
| CAREFUSION Corp (CFN) Delisted | Director | 34,103 | — | — | $0 | 9 | 2014-11-06 |
| MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted | Director | 0 | — | — | $0 | 8 | 2008-05-15 |
Recent Filings · Page 7 of 10
98 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-12-13 | XYL | Grant (A) | +1,400 | $0 | EDGAR |
| 2012-11-06 | CAREFUSION Corp (CFN) Delisted | Exer (M) | +6,019 | $0 | EDGAR |
| 2012-10-02 | REVVITY, INC. (PKI) Delisted | Mixed | — | -$350.8K | EDGAR |
| 2012-09-14 | REVVITY, INC. (PKI) Delisted | Mixed | — | -$324.6K | EDGAR |
| 2012-08-08 | REVVITY, INC. (PKI) Delisted | Sell (S) | −50,000 | -$1.40M | EDGAR |
| 2012-02-09 | REVVITY, INC. (PKI) Delisted | Mixed | +51,075 | -$262.8K | EDGAR |
| 2012-01-31 | REVVITY, INC. (PKI) Delisted | Tax (F) | −11,883 | -$286.6K | EDGAR |
| 2011-11-03 | CAREFUSION Corp (CFN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-08-16 | CAREFUSION Corp (CFN) Delisted | Exer (M) | +5,533 | $0 | EDGAR |
| 2011-08-02 | REVVITY, INC. (PKI) Delisted | Sell (S) | −20,000 | -$489.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.